Back

Determinants of myocardial injury following transcatheter aortic valve implantation: a pre-specified substudy from the POPular TAVI trial

26 August 2022 (12:15 - 13:00)
Organised by:
Congress Presentation Part of: Pharmacology and bleeding/ischaemica trade-off Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Dirk Jan van Ginkel

St Antonius Hospital, Nieuwegein (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Early in-hospital discontinuation of aspirin following coronary stent implantation in patients with indication for direct oral anticoagulation
Doctor P. von Stein (Cologne, DE)
Abstract Slides
Presentation thumbnail
Bleeding in patients undergoing percutaneous coronary intervention: factors associated with procedural outcomes and major bleeding complications
Doctor T. Bimal (Port Jefferson, US)
Abstract Slides
Presentation thumbnail
Prevalence and impact of TWILIGHT criteria in all-comer patients undergoing percutaneous coronary intervention
Doctor W. Koh (New York, US)
Abstract Slides
Presentation thumbnail
Dual versus single antiplatelet therapy after transcatheter aortic valve replacement: a systematic review and meta-analysis
Doctor R. Eikelboom (Hamilton, CA)
Abstract Slides
Presentation thumbnail
Reduction of major adverse and major cardiovascular events in patients with atrial fibrillation and stent implantation treated with left atrial occlusion device vs oral anticoagulants strategy.
Professor J. Lopez-Minguez (Badajoz, ES)
Abstract Slides

Access the full session

Session thumbnail
Pharmacology and bleeding/ischaemica trade-off

The Event

Event poster

ESC Congress 2022

26 August 2022 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Aortic regurgitation and stenosis: diagnosis and mode of intervention
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Session
Controversies in heart valve disease: integrating art, science, medicine, and surgery into decision-making

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources